FDA Approved: BREKIYA — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Brekiya (dihydroergotamine mesylate) from Amneal Pharmaceuticals in an original application for the acute treatment of migraine in adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• BREKIYA (Dihydroergotamine mesylate)

Snippet

ORIG AP for BREKIYA (DIHYDROERGOTAMINE MESYLATE)